Immuneering Corp

IMRX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.3B · 53 employees
77
SEC Filings
$5.77
Close 2026-05-29
53
Employees

Business Summary

EX-23.1 3 imrx-2021231x10kxexx231.htm EX-23.1 Document Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements (Nos. 333-289589 and 333-289997) on Form S-3 and Registration Statements (Nos. 333-258416 and 333-286973) on Form S-8 of Immuneering Corporation of our report dated March6, 2026, relating to the consolidated financial statements of Immuneering Corporation and its subsidiaries, appearing in this Annual Report on...

Latest Stock Quote

IMRX 2026-05-29 $5.77 O:$5.17 H:$5.845 L:$5.06 Vol:2.9M VWAP:$5.5137
origin leaf: fc4ed6df491e6d9e83542039ee31bd6ae6bcb352a4274a9ac6524f079cc8ac4a

Next Earnings

Q2 FY2026 — expected 2026-09-17

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-062025-12-310001790340-26-000042EDGAR100K words
2025-03-202024-12-310001790340-25-000042EDGAR
2024-03-012023-12-310001790340-24-000024EDGAR
2023-03-062022-12-310001558370-23-002905EDGAR
2022-03-102021-12-310001558370-22-003208EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001790340-25-000135EDGAR70K words
2025-08-132025-06-300001790340-25-000104EDGAR
2025-05-052025-03-310001790340-25-000061EDGAR
2024-11-132024-09-300001790340-24-000080EDGAR
2024-08-062024-06-300001790340-24-000066EDGAR
2024-05-072024-03-310001790340-24-000056EDGAR
2023-11-092023-09-300001790340-23-000056EDGAR
2023-08-032023-06-300001790340-23-000048EDGAR
2023-05-042023-03-310001790340-23-000023EDGAR
2022-11-102022-09-300001558370-22-017304EDGAR
2022-08-102022-06-300001558370-22-013063EDGAR
2022-05-102022-03-310001558370-22-007953EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-060001790340-26-000040EDGAR3K words
2026-01-070001790340-26-000006EDGAR
2025-11-120001790340-25-000133EDGAR
2025-09-250001104659-25-093436EDGAR
2025-09-240001104659-25-092957EDGAR
2025-08-250001104659-25-081995EDGAR
2025-08-130001790340-25-000102EDGAR
2025-06-170001790340-25-000077EDGAR
2025-06-160001790340-25-000063EDGAR
2025-05-050001790340-25-000059EDGAR

77 total filings indexed. 50 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001790340
TickerIMRX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.immuneering.com
Listed2021-07-30

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: af88fa5cbc1cec4bae94431095d04be0a6c3c4e0bcb036a7689958d1f2e8c426
parent: 9e945877682b6c2d20ccd705c97f09d6752046594346e450889b5eeba86de989
content hash: 0d52fa9263e0217aacb1d506132c08406c6df5057fbacf87318d4ebe3ac50533
signed: 2026-06-02T19:01:30.770Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf